Faced with the lack of evidence-based medicine concerning the efficacy and tolerance of cancer treatments in the extremely heterogeneous elderly population, and with no standardised geriatric evaluation in geriatric oncology clinical trials, the intergroup Dialog set itself the objective of establishing a minimal standardised geriatric evaluation for clinical trials. The evaluation must be simple, short and effective. It must comprise validated and reproducible measurement tools. The Geriatric Core Dataset, made up of seven items, has been formalised and validated by national and international experts.
[Clinical trials and elderly patients with cancer, the Geriatric Core Dataset (G-Code) tool].
Soins Gerontol. 2019;24(137):35-37.
MeSH terms: Aged; Clinical Trials as Topic; Datasets as Topic; Geriatric Assessment; Humans; Neoplasms
DOI: 10.1016/j.sger.2019.03.010